183 related articles for article (PubMed ID: 30030460)
41. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
[TBL] [Abstract][Full Text] [Related]
42.
Wollman A; Daniel T; Rosenzweig T
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31847157
[TBL] [Abstract][Full Text] [Related]
43. Antiviral and Virucidal Activities of
de Lima RC; Valente LMM; Familiar Macedo D; de-Oliveira-Pinto LM; Dos Santos FB; Mazzei JL; Siani AC; Nunes PCG; de Azeredo EL
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543735
[No Abstract] [Full Text] [Related]
44. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
45. LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD).
Soares e Silva AK; de Oliveira Cipriano Torres D; dos Santos Gomes FO; dos Santos Silva B; Lima Ribeiro E; Costa Oliveira A; dos Santos LA; de Lima Mdo C; Pitta Ida R; Peixoto CA
PLoS One; 2015; 10(4):e0123787. PubMed ID: 25875942
[TBL] [Abstract][Full Text] [Related]
46. Eugenol modulates insulin sensitivity by upregulating insulin receptor substrate-2 in non-alcoholic fatty liver disease in rats.
Fawzy MH; Saeed NM; El-Sherbiny DA; El-Demerdash E
J Pharm Pharmacol; 2021 Apr; 73(6):846-854. PubMed ID: 33822104
[TBL] [Abstract][Full Text] [Related]
47. The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice.
Cossiga V; Lembo V; Nigro C; Mirra P; Miele C; D'Argenio V; Leone A; Mazzone G; Veneruso I; Guido M; Beguinot F; Caporaso N; Morisco F
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33924725
[TBL] [Abstract][Full Text] [Related]
48. Antitumoral and antioxidant effects of a hydroalcoholic extract of cat's claw (Uncaria tomentosa) (Willd. Ex Roem. & Schult) in an in vivo carcinosarcoma model.
Dreifuss AA; Bastos-Pereira AL; Avila TV; Soley Bda S; Rivero AJ; Aguilar JL; Acco A
J Ethnopharmacol; 2010 Jul; 130(1):127-33. PubMed ID: 20435132
[TBL] [Abstract][Full Text] [Related]
49. Prevention of experimental diabetes by Uncaria tomentosa extract: Th2 polarization, regulatory T cell preservation or both?
Domingues A; Sartori A; Golim MA; Valente LM; da Rosa LC; Ishikawa LL; Siani AC; Viero RM
J Ethnopharmacol; 2011 Sep; 137(1):635-42. PubMed ID: 21718770
[TBL] [Abstract][Full Text] [Related]
50. Polyphenol-Rich Fraction of Ecklonia cava Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice.
Park EY; Choi H; Yoon JY; Lee IY; Seo Y; Moon HS; Hwang JH; Jun HS
Mar Drugs; 2015 Nov; 13(11):6866-83. PubMed ID: 26569269
[TBL] [Abstract][Full Text] [Related]
51. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
Wu L; Liu Y; Zhao Y; Li M; Guo L
Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
[TBL] [Abstract][Full Text] [Related]
52. Curcumin analog CUR5-8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity.
Lee ES; Kwon MH; Kim HM; Woo HB; Ahn CM; Chung CH
Metabolism; 2020 Feb; 103():154015. PubMed ID: 31758951
[TBL] [Abstract][Full Text] [Related]
53. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.
Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF
Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632
[TBL] [Abstract][Full Text] [Related]
54. Combination of metformin and chlorogenic acid attenuates hepatic steatosis and inflammation in high-fat diet fed mice.
Zamani-Garmsiri F; Ghasempour G; Aliabadi M; Hashemnia SMR; Emamgholipour S; Meshkani R
IUBMB Life; 2021 Jan; 73(1):252-263. PubMed ID: 33326684
[TBL] [Abstract][Full Text] [Related]
55. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
[TBL] [Abstract][Full Text] [Related]
56. Triticum aestivum ethanolic extract improves non-alcoholic fatty liver disease in mice fed a choline-deficient or high-fat diet.
Oh HS; Cho W; Tak SB; Kim S; Hong SP; Kim SO
J Sci Food Agric; 2019 Mar; 99(5):2602-2609. PubMed ID: 30414175
[TBL] [Abstract][Full Text] [Related]
57. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
[TBL] [Abstract][Full Text] [Related]
58. Effects of Chinese Medicinal Formula BNG-1 on Phosphodiesterase 3B Expression, Hepatic Steatosis, and Insulin Resistance in High Fat Diet-induced NAFLD Mice.
Guo CH; Chen WL; Liao CH; Huang K; Chen PY; Yang CP
Int J Med Sci; 2018; 15(11):1194-1202. PubMed ID: 30123057
[No Abstract] [Full Text] [Related]
59. Treatment with
Zari A; Alfarteesh H; Buckner C; Lafrenie R
Molecules; 2021 Feb; 26(4):. PubMed ID: 33670520
[No Abstract] [Full Text] [Related]
60. Zinc alpha2 glycoprotein protects against obesity-induced hepatic steatosis.
Xiao XH; Wang YD; Qi XY; Wang YY; Li JY; Li H; Zhang PY; Liao HL; Li MH; Liao ZZ; Yang J; Xu CX; Wen GB; Liu JH
Int J Obes (Lond); 2018 Aug; 42(8):1418-1430. PubMed ID: 30006580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
